DealBook: Sun Pharmaceuticals of India to Buy Ranbaxy, a Smaller Rival

Sun Pharmaceutical Industries, the Indian drug maker, said on Sunday that it would pay about $4 billion in stock for Ranbaxy Laboratories, a smaller Indian rival.

via NYT > Business Day http://ift.tt/1ijukeV

via WordPress http://ift.tt/1e7k6CN

via All Business Is Good Business http://ift.tt/QWsYB9

via May 21st 2011 wrong http://ift.tt/1mTICaf